LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Wholesale & Distribution Businesses for Sale
Restaurants for Sale
Gift & Flower Shops for Sale
Furniture & Home Decor Businesses for Sale
Service Businesses for Sale
Construction & Landscaping Businesses for Sale
Coin Laundry & Dry Cleaning Businesses for Sale
Beauty & Personal Care Businesses for Sale
Entertainment & Recreation Businesses for Sale
Warehouse & Storage Businesses for Sale
Smoke & Vape Shop Franchises for Sale
Retail Franchise Opportunities
Vending & Kiosk Franchises for Sale
Consultancy & Training Franchise Opportunities
Entertainment & Recreation Franchise Opportunities
Bars & Pubs Franchises for Sale
Technology Franchise Opportunities
Fitness & Wellness Franchises for Sale
Furniture & Home Decor Franchise Opportunities
Restaurant Franchises for Sale
Commercial Spaces for Sale or Lease
Miscellaneous Properties for Sale or Lease
Plazas for Sale
Mixed Use Buildings for Sale or Rent
Industrial Units for Sale or Rent
Office Spaces for Sale or Rent
Places of Worship for Sale
Industrial Buildings for Sale or Lease
Houses & Condos for Sale or Lease
Commercial Buildings for Sale or Lease
An email will be sent to registered email address.
Please select if you are: